BIOTRONIK Launches the Lumax 740 Series With ProMRI(R)
BIOTRONIK Launches the Lumax 740 Series With ProMRI(R)
  • Korea IT Times (
  • 승인 2012.04.16 15:53
  • 댓글 0
이 기사를 공유합니다

BERLIN, GERMANY — BIOTRONIK, a leading manufacturer of innovative medical technology, announced today the European full market release of the new Lumax 740 ICDs (implantable cardiac defibrillators) and CRT-Ds (cardiac resynchronization therapy defibrillators) in the European market. The Lumax 740 is the world‘s first and only ICD and CRT-D series approved for magnetic resonance imaging (MRI)(1), now giving ICD and CRT-D patients access to vital MR scans with BIOTRONIK’s innovative ProMRI(R) technology. 
“With its new Lumax 740 series BIOTRONIK is offering physicians and their patients access to state of the art diagnostics and the freedom to select the optimal ICD system for each patient's indication. The development of the new ProMRI(R) technology really represents a significant improvement in patient care,” commented Professor Dr. Wilhelm Haverkamp, Charité University Hospital Berlin, Virchow-Clinic Campus, Germany. 
Currently patients with standard ICDs are not allowed to have MR scans for safety reasons, yet 50-75% of them will be indicated for an MR scan during the lifetime of their device.(2) Worldwide, the population of patients who need an ICD is growing at a rate of about 10-15% annually. At the same time, the need for MR scans is also increasing at a rate of about 10% each year. Approximately 30 million scans were performed in 2006, and in 2010, there were already about 50 million MR scans conducted worldwide.(3) 
MR scanning is the ‘gold standard’ for soft tissue imaging. It is critical for the diagnosis and therapy of serious medical conditions such as cancer and strokes and delivers superior imaging quality and does not expose patients to radiation. 
Advanced Patient Therapy 
The new BIOTRONIK Lumax 740 series offers not only the world‘s first ICDs and CRT-Ds approved for MR scans, but further unique therapy options such as the world’s only single-chamber ICD with complete atrial diagnostics -- the Lumax 740 VR-T DX. Innovative solutions for heart failure patients are integrated in the Lumax 740 HF-T device that enables enhanced CRT effectiveness and includes a new research feature which measures the Intracardiac Impedance (ICI). The new sensor analyzes changes in impedance during the cycle of the heart and is being evaluated in clinical studies. This new feature aims to enhance therapy for heart failure patients in the future. 
Broadest portfolio gives access to advanced care 
“The Lumax 740 series is a broad portfolio of ICDs, CRT-D devices and leads which enables physicians to choose the best device and lead combination for each patient, along with giving those patients the opportunity for potentially lifesaving MRI procedures,” explains Professor Antonio Curnis, MD, Director Cardiac Pacing and Electrophysiology Lab, University of Brescia, Brescia City Hospital, Italy. 
“Because continuous, reliable monitoring is vitally important - especially for those who suffer from heart failure,” continued Professor Curnis, “the Lumax 740 system also integrates a sophisticated remote patient management system. BIOTRONIK Home Monitoring(R) and the Heart Failure Monitor enhance a patient's quality of life, and patients know that with these features their physicians can track their conditions remotely. It brings them great peace of mind to know they are being monitored and that any adjustments to their therapies can be made earlier.” 
BIOTRONIK Home Monitoring(R) is the first and only remote patient management system with FDA and CE approvals for safe reduction of in-office follow-ups and for early detection of clinically relevant events. Studies have demonstrated that BIOTRONIK Home Monitoring(R) enables an early detection of atrial fibrillation and a significant reduction of hospitalizations (COMPAS(4)) and that it also reduces unnecessary and inappropriate shocks (ECOST(5)). 
The new Lumax 740 series is part of BIOTRONIK‘s technologically advanced tachycardia product portfolio with ProMRI(R), which includes 3 ICDs, 1 CRT-D device and 16 leads. The Linoxsmart ICD leads, which have been proven over time to be of the highest quality and reliability, are now approved for MR scanning. In addition to featuring ProMRI(R) technology, the devices also stand out in the industry because they provide longevities of up to 11 years. Together with its MRI-approved Evia and Estella pacemaker series, BIOTRONIK offers patients the industry’s broadest portfolio of implantable cardiac devices approved for MR scanning. 

삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.

  • Korea IT Times: Copyright(C) 2004, Korea IT Times. .Allrights reserved.
  • #1206, 36-4 Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea(Postal Code 07331)
  • 서울특별시 영등포구 여의도동 36-4 (국제금융로8길 34) / 오륜빌딩 1206호
  • * Mobile News:
  • * Internet news:
  • * Editorial Div. 02-578-0434 / 010-2442-9446 * PR Global/AD: 82-2-578-0678.
  • * IT Times Canada: Willow St. Vancouver BC
  • 070-7008-0005
  • * Email: